Skip to main content
Caplight Logo









Olio Labs

Olio Labs

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://oliolabs.co/

Last Round

Seed

Mar 19, 2025

Total Funding Raised

$8.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Olio Labs is a biotechnology company that develops a therapeutic design platform utilizing artificial intelligence to create combination therapeutics for complex diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

drug discoverycombination therapeuticsin silico testingAI drug discoverycomputational biologymulti-target therapypreclinical researchprotein interactionbiotech AIdrug designin silico drug discoveryAI-driven R&Dprecision medicinepharma techcomputational drug design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Olio Labs Comparables

Compare Olio Labs with similar companies based on industry and business-model similarity.

Olio Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Algen Biotechnologies
80%
Eigen Therapeutics
78%
Superluminal Medicines
77%

Olio Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 19, 2025
SeedJul 1, 2023

Key People

Founding team and executive leadership

Tom Roseberry

Co-Founder CTO

Founding Team

Olio Labs Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Grew 44% QoQ from 9 to 13 employees.

  • Mar 19, 2025

    $5M Series A round completed.

Recent news

Latest coverage and updates

  • launchesAug 5, 2026

    Olio Labs, Inc. launches AI-driven in vivo platform.

Olio Labs Filings

Explore SEC and related filing metadata, where available.

Olio Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Olio Labs's valuation, stock price, and market status.

Is Olio Labs a public or private company?

Olio Labs is a private company.

What is the current stock price of Olio Labs?

Olio Labs is a private company with no public stock price. No recent secondary market data is available.

How much is Olio Labs worth (valuation)?

Valuation information for Olio Labs is not publicly available.

Can I buy Olio Labs stock?

Olio Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Olio Labs's last funding round?

Olio Labs's most recent funding round was Series A on March 19, 2025.

Who are the main investors in Olio Labs?

Key investors in Olio Labs include Boom Capital, Y Combinator, Overwater Ventures.

Will Olio Labs IPO soon?

No public IPO plans have been announced for Olio Labs.

How can I track Olio Labs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Olio Labs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range8
Year Founded2023
Last FundingMar 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?